Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4+ type 2 rather than type 1 immune response that is not protective

Infection and Immunity

Volumn 70, Issue 3, 2002, Pages 1097-1105

  Shaw, Jennifer ^a   Grund, Vernon ^a   Durling, Luke ^a   Crane, Debbie ^a   Caldwell, Harlan D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 12; RECOMBINANT ANTIGEN; RECOMBINANT CHLAMYDIAL MAJOR OUTER MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ANTIGEN DETECTION; ARTICLE; BLINDNESS; CELL PROLIFERATION; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG DELIVERY SYSTEM; DRUG PULSE THERAPY; FEMALE; GENETIC CORRELATION; GENITAL TRACT INFECTION; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TRACHOMA; VACCINE PRODUCTION;

ADOPTIVE TRANSFER; ANIMALS; BACTERIAL VACCINES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DENDRITIC CELLS; FEMALE; INTERFERON TYPE II; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; PHAGOCYTOSIS; PORINS; TH2 CELLS; VACCINATION;

EID: 0036178026     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.3.1097-1105.2002     Document Type: Article

References (49)

1. A new animal model for the study of Chlamydia trachomatis genital infections: Infection of mice with the agent of mouse pneumonitis
2. Chemical, biological, and immunochemical properties of the Chlamydia psittaci lipopolysaccharide
3. Structural analysis of chlamydial major outer membrane proteins
4. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis
5. Antigenic analysis of the major outer membrane protein of Chlamydia spp.
6. A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections
7. Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes
8. 1 lymphocyte clone
9. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
10. The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated
11. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response
12. Studies in knockout mice reveal that anti-chlamydial protection requires TH1 cells producing IFN-y: Is this true for humans?
13. B-cell-deficient mice develop complete immune protection against genital tract infection with Chlamydia trachomatis
14. Cutting edge: Heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells
15. Chlamydial lipopolysaccharide
16. CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo
17. Cytokines regulate the capacity of cd8alpha(+) and cd8alpha(-) dendritic cells to prime th1/th2 cells in vivo
18. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection
19. Immunology of Chlamydia trachomatis infections: Immunoprotective and immunopathogenetic responses
20. + T cells
21. + T cells
22. Interaction of chlamydiae and host cells in vitro
23. Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge
24. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-y-dependent and -independent pathways
25. Chlamydial infections (first of three parts)
26. Chlamydiae
27. Expression of genes encoding Th1 cell-activating cytokines and lymphoid homing chemokines by Chlamydia-pulsed dendritic cells correlates with protective immunizing efficacy
28. Vaccines against Chlamydia: Approaches and progress
29. The dendritic cell system and its role in immunogenicity
30. Dendritic cells in the T-cell areas of lymphoid organs
31. Advances, challenges, and changing paradigms
32. + T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract
33. Immunogenicity of a chimeric peptide corresponding to T helper and B cell epitopes of the Chlamydia trachomatis major outer membrane protein
34. Immunogenicity of a synthetic oligopeptide corresponding to antigenically common T-helper and B-cell neutralizing epitopes of the major outer membrane protein of Chlamydia trachomatis
35. In vitro neutralization of Chlamydia trachomatis by monovalent Fab antibody specific to the major outer membrane protein
36. Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice
37. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae
38. A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells
39. Chlamydia trachomatis-host cell interactions: Role of the chlamydial major outer membrane protein as an adhesin
40. Differential effect of trypsin on infectivity of Chlamydia trachomatis: Loss of infectivity requires cleavage of major outer membrane protein variable domains II and IV
41. Heterotypic protection of mice against chlamydial salpingitis and colonization of the lower genital tract with a human serovar F isolate of Chlamydia trachomatis by prior immunization with recombinant serovar L1 major outer-membrane protein
42. Salpingitis in mice induced by human strains of Chlamydia trachomatis
43. The chlamydial developmental cycle
44. Chlamydial vaccines - Future trends
45. Computer modelling of trachoma control strategies
46. Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis
47. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis